PERLA ZAMBRANO: Open Payments
NPI 1649229980 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 62 payments from 25 companies in 2025. Trend: 2023 $1,418 · 2024 $2,295 · 2025 $1,646
Food & beverage: $1,515Education: $132
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $204 |
| Genentech USA, Inc. | 4 | $128 |
| Caris MPI, Inc. | 3 | $106 |
| AstraZeneca Pharmaceuticals LP | 2 | $96 |
| Lilly USA, LLC | 1 | $86 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| ARRAY BIOPHARMA INC | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
Products named: MI CANCER SEEK, ERLEADA, RYBREVANT, Onivyde, ELAHERE, Tecentriq, Itovebi, BRAFTOVI.
Industry payments across FL — which companies pay providers there.
